Renato D. Lópes
Researcher Next ID · RN-024385
Researcher · Medicine
Alnylam Pharmaceuticals (United States)
Cambridge, Brazil
- Works count
- 1,228
- Citation count
- 67,730
- H-index
- 117
- i10-index
- 548
Research interests
Publications
Empagliflozin after Acute Myocardial Infarction
New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2314051
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2310234
Survival After Invasive or Conservative Management of Stable Coronary Disease
Circulation · 2022 · https://doi.org/10.1161/circulationaha.122.062714
Diagnosis and Treatment of Acute Coronary Syndromes
JAMA · 2022 · https://doi.org/10.1001/jama.2022.0358
Survival After Invasive or Conservative Management of Stable Coronary Disease
Circulation · 2022 · https://doi.org/10.1161/circulationaha.122.062714
Survival After Invasive or Conservative Management of Stable Coronary Disease
Circulation · 2022 · https://doi.org/10.1161/circulationaha.122.062714
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis
New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2113380
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
The Lancet Diabetes & Endocrinology · 2021 · https://doi.org/10.1016/s2213-8587(21)00203-5
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2108269
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31862-6
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
New England Journal of Medicine · 2020 · 10.1056/nejmoa2030183
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2019014
Initial Invasive or Conservative Strategy for Stable Coronary Disease
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1915922
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
JAMA · 2020 · https://doi.org/10.1001/jama.2020.17021
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes & Endocrinology · 2019 · https://doi.org/10.1016/s2213-8587(19)30158-5
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
New England Journal of Medicine · 2019 · 10.1056/nejmoa1817083
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes & Endocrinology · 2019 · https://doi.org/10.1016/s2213-8587(19)30158-5
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
The Lancet · 2018 · 10.1016/s0140-6736(18)32261-x
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)32165-7
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
The Lancet · 2017 · 10.1016/s0140-6736(17)32247-x
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)32165-7
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
European Heart Journal · 2016 · https://doi.org/10.1093/eurheartj/ehw054
Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
Journal of the American College of Cardiology · 2014 · https://doi.org/10.1016/j.jacc.2014.02.549
Current projects
No projects listed.